From: Progesterone receptor isoform A may regulate the effects of neoadjuvant aglepristone in canine mammary carcinoma
Median ± SD of PRA expression (2^∆-Ct)
PRA status at day 1
Day 1
Day 15
Control group
PRA+
0.05 ± 0.02
0.08 ± 0.06
PRA-
0.01 ± 0.01
0.03 ± 0.00
Treated group
0.08 ± 0.05
0.04 ± 0.02*
0.02 ± 0.04